Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: A 16-year retrospective cohort study

Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: A 16-year retrospective cohort study

Background: Intravenous indomethacin has been used in infants for many years as the pharmacological closure of ductus arteriosus, but the incidence, risk, and risk factors of acute kidney injury (AKI) among infants treated with indomethacin, were still scarce. Objectives: To determine the incidence,...

Full description

Bibliographic Details
Main Authors: Dissaneevate, S. (Author), Janjindamai, W. (Author), Raknoo, T. (Author), Ratanajamit, C. (Author), Sitaruno, S. (Author)
Format: Article
Language:English
Published: Grupo de Investigacion en Atencion Farmaceutica 2021
Subjects:
acute kidney failure
Acute Kidney Injury
amikacin
aminoglycoside
amphotericin B
aortic root
apnea
Article
artificial ventilation
birth weight
brain hemorrhage
cohort analysis
Cohort Studies
corticosteroid
creatinine blood level
dexamethasone
disease severity
dobutamine
dopamine
Ductus Arteriosus, Patent
echocardiography
epinephrine
extremely low birth weight
female
furosemide
gentamicin
gestational age
human
hydrocortisone
hypertensive agent
ICD-10
incidence
indometacin
Indomethacin
infant
Infant
inotropic agent
kidney failure
kidney function
low birth weight
lung dysplasia
male
meconium aspiration
milrinone
necrotizing enterocolitis
neonatal intensive care unit
newborn
newborn jaundice
noradrenalin
patent ductus arteriosus
perinatal asphyxia
prematurity
pulmonary hypertension
Renal Insufficiency
respiratory distress syndrome
retrospective study
risk factor
shunting
urine volume
vancomycin
very low birth weight
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items